Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Chronic hyperphosphatemia leads to increased mortality in maintenance hemodialysis (MHD) patients. While both plant-based (PB) and animal-based (AB) proteins contain phosphorus, the presence of phytate in plant sources may offer a unique advantage by reducing intestinal absorption of this mineral. Limited evidence exists on whether PB protein, compared to AB protein, can better control phosphate levels among this population.
This randomized, controlled, cross-over trial enrolled MHD patients with chronic hyperphosphatemia. Participants were randomly assigned to consume either PB or AB protein for 2 weeks, with a 2-week washout between interventions. Serum phosphate, electrolytes, pre-albumin, dietary intake, and muscle mass were assessed through the study. The main outcome was mean change in serum phosphate level.
A Total of 201 patients were screened, of whom 12 MHD patients were enrolled in the studied. Both groups consumed similar protein intake (1.24 vs. 1.15 g/kg/day, P=0.185), but the PB group had significantly higher phosphate intake (920 vs. 621 mg/day, P<0.001). At the end of the study, a significantly lower proportion of patients in the PB group had serum phosphate levels below 5 mg/dL, which is considered optimal for this population (50% vs. 8.3%, P=0.025). Additionally, the mean change in serum phosphate level was significantly lower in the PB group compared to the AB group (-1.34±1.8 vs. -0.24±1.32 mg/dL, P=0.041). No significant differences in the mean change of electrolytes, prealbumin, and muscle mass were observed between groups.
In conclusions, this study suggests that PB protein consumption may be a promising strategy for managing hyperphosphatemia in dialysis patients without compromising other aspects of health.
